Hasil Pencarian - Franssen FME

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease

    Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease oleh Wouters EFM, Spruit MA, Franssen FME

    Diterbitkan 2011-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Lung Hyperinflation as Treatable Trait in Chronic Obstructive Pulmonary Disease: A Narrative Review

    Lung Hyperinflation as Treatable Trait in Chronic Obstructive Pulmonary Disease: A Narrative Review oleh Koopman M, Posthuma R, Vanfleteren LEGW, Simons SO, Franssen FME

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study

    Differential Response to 12 Weeks of Once-Daily Tiotropium/Olodaterol Fixed Dose Combination in Patients with COPD: A Multidimensional Response Profiling in the TORRACTO Study oleh Posthuma R, Vanfleteren LEGW, Gaffron S, Vaes AW, Franssen FME, Spruit MA

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Vitamin D Status and Longitudinal Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease – A Prospective Observational Study

    Vitamin D Status and Longitudinal Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease – A Prospective Observational Study oleh Minter M, van Odijk J, Augustin H, Machado FVC, Franssen FME, Spruit MA, Vanfleteren LEGW

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Sputum microbiology predicts health status in COPD

    Sputum microbiology predicts health status in COPD oleh Braeken DCW, Houben-Wilke S, Smid DE, Rohde GGU, Drijkoningen J JC, Wouters EFM, Spruit MA, Franssen FME

    Diterbitkan 2016-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom

    Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom oleh Braeken DCW, Rohde GGU, Franssen FME, Driessen JHM, van Staa TP, Souverein PC, Wouters EFM, de Vries F

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis

    Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis oleh de Blasio F, de Blasio F, Miracco Berlingieri G, Bianco A, La Greca M, Franssen FME, Scalfi L

    Diterbitkan 2016-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Domain-specific cognitive impairment in patients with COPD and control subjects

    Domain-specific cognitive impairment in patients with COPD and control subjects oleh Cleutjens FAHM, Franssen FME, Spruit MA, Vanfleteren LEGW, Gijsen C, Dijkstra JB, Ponds RWHM, Wouters EFM, Janssen DJA

    Diterbitkan 2016-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort

    External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort oleh Keene SJ, Jordan RE, Franssen FME, de Vries F, Martin J, Sitch A, Turner AM, Dickens AP, Fitzmaurice D, Adab P

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Personalized medicine for patients with COPD: where are we?

    Personalized medicine for patients with COPD: where are we? oleh Franssen FME, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, Maxheim M, Roessler FK, Spruit MA, Vogelmeier CF, Wouters EFM, Schmeck B

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale

    Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale oleh Janssen R, Wouters EFM, Janssens W, Daamen WF, Hagedoorn P, de Wit HAJM, Serré J, Gayan-Ramirez G, Franssen FME, Reynaert NL, von der Thüsen JH, Frijlink HW

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus

    Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus oleh Ramakrishnan S, Janssens W, Burgel PR, Contoli M, Franssen FME, Greening NJ, Greulich T, Gyselinck I, Halner A, Huerta A, Morgan RL, Quint JK, Vanfleteren LEGW, Vermeersch K, Watz H, Bafadhel M

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study

    Differential Outcomes Following 4 Weeks of Aclidinium/Formoterol in Patients with COPD: A Reanalysis of the ACTIVATE Study oleh Koopman M, Franssen FME, Gaffron S, Watz H, Troosters T, Garcia-Aymerich J, Paggiaro P, Molins E, Moya M, van Burk L, Maier D, Garcia Gil E, Wouters EFM, Vanfleteren LEGW, Spruit MA

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: